Last year’s warnings from the FDA about dose-dependent QTc elongation and cardiac arrhythmias including Torsade De Pointes among patients taking citalopram at higher doses have been supplemented by warnings issued by HealthCanada on escitalopram (Lexapro), the S-isomer of racemic citalopram. The FDA’s 2012 guidelines exclude escitalopram but hedge on concluding that the QT effects are […]
Tags: cardiac warning, celexa, citalopram, escitalopram, lexapro